XM does not provide services to residents of the United States of America.

Australia shares jump as strong US data calms recession fears



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Australia shares jump as strong US data calms recession fears</title></head><body>

Aug 16 (Reuters) -Australian shares climbed in a broad-based rally on Friday, tracking strong gains on Wall Street overnight after robust U.S. retail sales data allayed worries about an imminent recession in the world's largest economy.

The S&P/ASX 200 index .AXJO rose 1.3% to 7,968.6 by 0103 GMT. The benchmark was up for a sixth straight session and was on track to post its best weekly gain since December.

Data showed that U.S. retail sales increased 1.0%, well above market forecasts, easing fears of a sharp economic slowdown, fanned by a jump in the unemployment rate last week.

Overnight, the U.S. Dow Jones Industrial Average .DJI rose 1.39% at 40,563.06. The S&P 500 .SPX gained 1.61%, while Nasdaq .IXIC gained 2.34%. .N

Traders pared back bets the Federal Reserve would be forced into aggressive easing next month.

Meanwhile, Australia's central banker said it was premature to be thinking about rate cuts, adding underlying inflation was too high.

In Sydney, heavyweight miners .AXMM rose 2.1% to lead gains, after Chinese iron ore futures DCIOcv1 on the Dalian Commodity Exchange rose 0.8%.

Banking stocks .AXFJ added 1.4%. The country's top business lender National Australia Bank NAB.AX reported a drop in its third quarter cash earnings, but credit impairment charge came in lower-than-expected. The stock rose 1.2%.

Energy stocks .AXEJ were up 2%. Brent crude LCOc1 futures fell 0.15%, while U.S. West Texas Intermediate (WTI) crude CLc1 lost 0.23%, but both were set for weekly gains. O/R

Tech .AXIJ, gold .AXGD and healthcare .AXHJ sub-indexes advanced between 0.9% and 1.7%.

Among individual stocks, bourse operator ASX Ltd ASX.AX dropped as much as 3.3% after its annual underlying profit slipped roughly 3% and missed market estimates.

New Zealand's benchmark S&P/NZX 50 index .NZ50 rose 0.3% to 12,745.43.

Synlait Milk SML.NZ and its shareholder a2 Milk ATM.NZ resolved disputes over exclusive manufacturing rights. a2 shares jumped over 4%, while Synlait rose 15%.






Reporting by Himanshi Akhand in Bengaluru; Editing by Rashmi Aich

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.